150 related articles for article (PubMed ID: 25799942)
1. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models.
McClintock SD; Warner RL; Ali S; Chekuri A; Dame MK; Attili D; Knibbs RK; Aslam MN; Sinkule J; Morgan AC; Barsoum A; Smith LB; Beer DG; Johnson KJ; Varani J
Cancer Biol Ther; 2015; 16(5):724-32. PubMed ID: 25799942
[TBL] [Abstract][Full Text] [Related]
2. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Siegel S; Wagner A; Kabelitz D; Marget M; Coggin J; Barsoum A; Rohrer J; Schmitz N; Zeis M
Blood; 2003 Dec; 102(13):4416-23. PubMed ID: 12869512
[TBL] [Abstract][Full Text] [Related]
3. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
Coggin JH; Barsoum AL; Rohrer JW
Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
[TBL] [Abstract][Full Text] [Related]
4. Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.
Barsoum AL; Liu B; Rohrer JW; Coggin JH; Tucker JA; Pannell LK; Schwarzenberger PO
Biomaterials; 2009 Jun; 30(17):3091-9. PubMed ID: 19268360
[TBL] [Abstract][Full Text] [Related]
5. Identification of oncofetal antigen/immature laminin receptor protein epitopes that activate BALB/c mouse OFA/iLRP-specific effector and regulatory T cell clones.
Rohrer JW; Barsoum AL; Coggin JH
J Immunol; 2006 Mar; 176(5):2844-56. PubMed ID: 16493041
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
Friedrichs B; Siegel S; Kloess M; Barsoum A; Coggin J; Rohrer J; Jakob I; Tiemann M; Heidorn K; Schulte C; Kabelitz D; Steinmann J; Schmitz N; Zeis M
J Immunol; 2008 May; 180(9):6374-84. PubMed ID: 18424761
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.
Biragyn A; Schiavo R; Olkhanud P; Sumitomo K; King A; McCain M; Indig FE; Almanzar G; Baatar D
J Immunol; 2007 Jul; 179(2):1381-8. PubMed ID: 17617631
[TBL] [Abstract][Full Text] [Related]
8. Identification of partial complementary DNA clones encoding a 59-kd protein with characteristics of a unique oncofetal antigen.
Rashid HU; Barsoum AL; Cao TM; Coggin JH
J Natl Cancer Inst; 1994 Apr; 86(7):515-26. PubMed ID: 8133535
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma.
Zelle-Rieser C; Barsoum AL; Sallusto F; Ramoner R; Rohrer JW; Höltl L; Bartsch G; Coggin JH JR; Thurnher M
J Urol; 2001 May; 165(5):1705-9. PubMed ID: 11342960
[TBL] [Abstract][Full Text] [Related]
10. Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells.
An Y; Hu Y; Li X; Li Z; Duan J; Yang XD
Sci Rep; 2019 May; 9(1):7343. PubMed ID: 31089250
[TBL] [Abstract][Full Text] [Related]
11. Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer.
Barsoum AL; Schwarzenberger PO
Cell Mol Biol Lett; 2014 Sep; 19(3):393-406. PubMed ID: 25082063
[TBL] [Abstract][Full Text] [Related]
12. Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model.
Martínez-Cortés F; Servín-Blanco R; Domínguez-Romero AN; Munguía ME; Guzman Valle J; Odales J; Gevorkian G; Manoutcharian K
Mol Immunol; 2021 Nov; 139():65-75. PubMed ID: 34454186
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor growth and metastatic spread of an MH134 variant lacking a part of the MM antigen: a possible role of antibody-dependent cellular cytotoxicity in control of tumor growth and metastases.
Hara H; Kawase I; Komuta K; Masuno T; Kishimoto S
Int J Cancer; 1989 Jul; 44(1):137-42. PubMed ID: 2744883
[TBL] [Abstract][Full Text] [Related]
14. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
[TBL] [Abstract][Full Text] [Related]
15. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
16. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties.
Gersten DM; Moody D; Vieira WD; Law LW; Hearing VJ
Biochim Biophys Acta; 1992 Feb; 1138(2):109-14. PubMed ID: 1540656
[TBL] [Abstract][Full Text] [Related]
17. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
[TBL] [Abstract][Full Text] [Related]
18. In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells--clinical implications.
Siegel S; Friedrichs B; Budde AK; Barsoum A; Coggin J; Tiemann M; Kabelitz D; Zeis M
Leukemia; 2008 Nov; 22(11):2115-8. PubMed ID: 18449203
[No Abstract] [Full Text] [Related]
19. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma.
Tsai NM; Chen BM; Wei SL; Wu CW; Roffler SR
Clin Exp Metastasis; 2003; 20(2):103-9. PubMed ID: 12705631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
